UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 12, 2017 5:00 P.M.

Form:	S-3
CIK: 0001638287 Company Name: Gemphire Therapeutics Inc. File Number: 333-220315